P Ross

441 total citations
13 papers, 375 citations indexed

About

P Ross is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, P Ross has authored 13 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Surgery. Recurrent topics in P Ross's work include Monoclonal and Polyclonal Antibodies Research (3 papers), Cancer Treatment and Pharmacology (2 papers) and T-cell and B-cell Immunology (2 papers). P Ross is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (3 papers), Cancer Treatment and Pharmacology (2 papers) and T-cell and B-cell Immunology (2 papers). P Ross collaborates with scholars based in United States, United Kingdom and Hungary. P Ross's co-authors include Richard D. Klausner, Lawrence E. Samelson, Jeffrey A. Bluestone, John J. O’Shea, Kenneth D. Flora, Roger Barton, Bryan D. Petersen, Kent G. Benner, Paul C. Lakin and Frederick S. Keller and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

P Ross

13 papers receiving 365 citations

Peers

P Ross

IMMUN

MB

SURGE

HEPAT

ONCOL

Chuichi Sekine Japan

Jane Birtwistle United Kingdom

Lujun Song China

Stefan A. Cohen United States

Huan Xu China

Huong‐Thu Ton‐Nu United States

Danielle G. Aspar United States

T Katsuki Japan

Judith A. Falk Canada

Fabio Ferrando Italy

Chuichi Sekine Japan

P Ross

79 ×0.6

IMMUN

154 ×1.3

MB

77 ×0.8

SURGE

97 ×1.3

HEPAT

45 ×0.6

ONCOL

Citations per year, relative to P Ross P Ross (= 1×) peers Chuichi Sekine

Countries citing papers authored by P Ross

Since Specialization

Citations

This map shows the geographic impact of P Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Ross more than expected).

Fields of papers citing papers by P Ross

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Ross. The network helps show where P Ross may publish in the future.

Co-authorship network of co-authors of P Ross

This figure shows the co-authorship network connecting the top 25 collaborators of P Ross. A scholar is included among the top collaborators of P Ross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Ross. P Ross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Zweifel, Martin, Mark R. Middleton, Patricia M. Price, et al.. (2012). Phase I Clinical and Pharmacokinetic Evaluation of the Vascular-Disrupting Agent OXi4503 in Patients with Advanced Solid Tumors. Clinical Cancer Research. 18(5). 1415–1425. 66 indexed citations

2.

Marinaki, Anthony M., et al.. (2010). PHARMACOGENETICS OF IRINOTECAN: MINIMISING TOXICITIES AND MAXIMISING CLINICAL RESPONSE. Annals of Oncology. 21. 1 indexed citations

3.

Zweifel, Martin, Daniel Patterson, Anwar R. Padhani, et al.. (2010). Phase I pharmacokinetic and pharmacodynamic evaluation of the vascular disrupting agent OXi4503 in patients with advanced solid tumors.. Journal of Clinical Oncology. 28(15_suppl). 2594–2594. 4 indexed citations

4.

Davies, Benjamin J., Thomas J. Walsh, P Ross, et al.. (2008). Effect of BMI on Primary Treatment of Prostate Cancer. Urology. 72(2). 406–411. 23 indexed citations

5.

Firth, James D., et al.. (1998). Biotransformation and pharmacokinetic analysis of oxaliplatin in patients with advanced gastrointestinal cancer. 39. 159. 13 indexed citations

6.

Ross, P, Roger Barton, Kent G. Benner, et al.. (1998). Transjugular intrahepatic portosystemic shunt patency and the importance of stenosis location in the development of recurrent symptoms.. Radiology. 207(3). 683–693. 80 indexed citations

7.

Ross, P, et al.. (1991). Clarification of the role of CT scan in the acute evaluation of blunt abdominal trauma.. PubMed. 55(6). 330–2. 4 indexed citations

8.

Harris, S. T., Harry K. Genant, R.D. Wasnich, et al.. (1991). Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. Maturitas. 13(1). 90–91. 5 indexed citations

9.

Weissman, Allan M., P Ross, Pilar García-Morales, et al.. (1988). Tyrosine phosphorylation of the human T cell antigen receptor zeta -chain: activation via CD3 but not CD2.. The Journal of Immunology. 141(10). 3532–3536. 48 indexed citations

10.

Ross, P, et al.. (1988). Acute cholecystitis complicating ERCP: a case report.. PubMed. 10(3). 350–1. 3 indexed citations

11.

Samelson, Lawrence E., et al.. (1987). T cell antigen receptor phosphorylation induced by an anti-receptor antibody.. The Journal of Immunology. 139(8). 2708–2714. 46 indexed citations

12.

Klausner, Richard D., et al.. (1987). T cell receptor tyrosine phosphorylation. Variable coupling for different activating ligands.. Journal of Biological Chemistry. 262(26). 12654–12659. 79 indexed citations

13.

Macmanus, Quentin, et al.. (1983). Pheochromocytoma as cause of hypertension after coronary bypass.. PubMed. 110(3). 183–5. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact